Survival and psychomotor development with early betaine treatment in patients with severe methylenetetrahydrofolate reductase deficiency.

Diekman, Eugene F

Survival and psychomotor development with early betaine treatment in patients with severe methylenetetrahydrofolate reductase deficiency. [electronic resource] - JAMA neurology Feb 2014 - 188-94 p. digital

Publication Type: Case Reports; Journal Article; Meta-Analysis; Review

2168-6157

10.1001/jamaneurol.2013.4915 doi


Adolescent
Betaine--administration & dosage
Child
Child, Preschool
Female
Homocystinuria--drug therapy
Humans
Infant
Infant, Newborn
Male
Methylenetetrahydrofolate Reductase (NADPH2)--deficiency
Muscle Spasticity--drug therapy
Psychomotor Disorders--enzymology
Psychotic Disorders--drug therapy
Severity of Illness Index
Survival Rate--trends
Treatment Outcome
Young Adult